Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

Idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD) differ in the predominant demographics and identified genetic risk alleles of effected patients, however both diseases frequently progress to respiratory failure and death. Contrasting advanced...

Full description

Bibliographic Details
Main Authors: Eleanor Valenzi, Tracy Tabib, Anna Papazoglou, John Sembrat, Humberto E. Trejo Bittar, Mauricio Rojas, Robert Lafyatis
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.595811/full
_version_ 1818930483568836608
author Eleanor Valenzi
Tracy Tabib
Anna Papazoglou
John Sembrat
Humberto E. Trejo Bittar
Mauricio Rojas
Robert Lafyatis
author_facet Eleanor Valenzi
Tracy Tabib
Anna Papazoglou
John Sembrat
Humberto E. Trejo Bittar
Mauricio Rojas
Robert Lafyatis
author_sort Eleanor Valenzi
collection DOAJ
description Idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD) differ in the predominant demographics and identified genetic risk alleles of effected patients, however both diseases frequently progress to respiratory failure and death. Contrasting advanced SSc-ILD to IPF provides insight to the role dysregulated immunity may play in pulmonary fibrosis. To analyze cell-type specific transcriptome commonalities and differences between IPF and SSc-ILD, we compared single-cell RNA-sequencing (scRNA-seq) of 21 explanted lung tissue specimens from patients with advanced IPF, SSc-ILD, and organ donor controls. Comparison of IPF and SSc-ILD tissue identified divergent patterns of interferon signaling, with interferon-gamma signaling upregulated in the SPP1hi and FABP4hi macrophages, cytotoxic T cells, and natural kill cells of IPF, while type I interferon signaling and production was upregulated in the corresponding SSc-ILD populations. Plasmacytoid dendritic cells were found in diseased lungs only, and exhibited upregulated cellular stress pathways in SSc-ILD compared to IPF. Alveolar type I cells were dramatically decreased in both IPF and SSc-ILD, with a distinct transcriptome signature separating these cells by disease. KRT5-/KRT17+ aberrant basaloid cells exhibiting markers of cellular senescence and epithelial-mesenchymal transition were identified in SSc-ILD for the first time. In summary, our study utilizes the enriched capabilities of scRNA-seq to identify key divergent cell types and pathways between IPF and SSc-ILD, providing new insights into the shared and distinct mechanisms between idiopathic and autoimmune interstitial lung diseases.
first_indexed 2024-12-20T04:01:25Z
format Article
id doaj.art-bc785957a44d45c49c778df6c7966fa8
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T04:01:25Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-bc785957a44d45c49c778df6c7966fa82022-12-21T19:54:09ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-03-011210.3389/fimmu.2021.595811595811Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung DiseaseEleanor Valenzi0Tracy Tabib1Anna Papazoglou2John Sembrat3Humberto E. Trejo Bittar4Mauricio Rojas5Robert Lafyatis6Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United StatesDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, United StatesDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, United StatesDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United StatesDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA, United StatesDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United StatesDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, United StatesIdiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD) differ in the predominant demographics and identified genetic risk alleles of effected patients, however both diseases frequently progress to respiratory failure and death. Contrasting advanced SSc-ILD to IPF provides insight to the role dysregulated immunity may play in pulmonary fibrosis. To analyze cell-type specific transcriptome commonalities and differences between IPF and SSc-ILD, we compared single-cell RNA-sequencing (scRNA-seq) of 21 explanted lung tissue specimens from patients with advanced IPF, SSc-ILD, and organ donor controls. Comparison of IPF and SSc-ILD tissue identified divergent patterns of interferon signaling, with interferon-gamma signaling upregulated in the SPP1hi and FABP4hi macrophages, cytotoxic T cells, and natural kill cells of IPF, while type I interferon signaling and production was upregulated in the corresponding SSc-ILD populations. Plasmacytoid dendritic cells were found in diseased lungs only, and exhibited upregulated cellular stress pathways in SSc-ILD compared to IPF. Alveolar type I cells were dramatically decreased in both IPF and SSc-ILD, with a distinct transcriptome signature separating these cells by disease. KRT5-/KRT17+ aberrant basaloid cells exhibiting markers of cellular senescence and epithelial-mesenchymal transition were identified in SSc-ILD for the first time. In summary, our study utilizes the enriched capabilities of scRNA-seq to identify key divergent cell types and pathways between IPF and SSc-ILD, providing new insights into the shared and distinct mechanisms between idiopathic and autoimmune interstitial lung diseases.https://www.frontiersin.org/articles/10.3389/fimmu.2021.595811/fullsystemic sclerosissystemic sclerosis (scleroderma)idiopathic pulmonary fibrosisinterstitial lung disease (ILD)single-cell RNA-sequencing (scRNA-seq)
spellingShingle Eleanor Valenzi
Tracy Tabib
Anna Papazoglou
John Sembrat
Humberto E. Trejo Bittar
Mauricio Rojas
Robert Lafyatis
Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
Frontiers in Immunology
systemic sclerosis
systemic sclerosis (scleroderma)
idiopathic pulmonary fibrosis
interstitial lung disease (ILD)
single-cell RNA-sequencing (scRNA-seq)
title Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
title_full Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
title_fullStr Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
title_full_unstemmed Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
title_short Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
title_sort disparate interferon signaling and shared aberrant basaloid cells in single cell profiling of idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease
topic systemic sclerosis
systemic sclerosis (scleroderma)
idiopathic pulmonary fibrosis
interstitial lung disease (ILD)
single-cell RNA-sequencing (scRNA-seq)
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.595811/full
work_keys_str_mv AT eleanorvalenzi disparateinterferonsignalingandsharedaberrantbasaloidcellsinsinglecellprofilingofidiopathicpulmonaryfibrosisandsystemicsclerosisassociatedinterstitiallungdisease
AT tracytabib disparateinterferonsignalingandsharedaberrantbasaloidcellsinsinglecellprofilingofidiopathicpulmonaryfibrosisandsystemicsclerosisassociatedinterstitiallungdisease
AT annapapazoglou disparateinterferonsignalingandsharedaberrantbasaloidcellsinsinglecellprofilingofidiopathicpulmonaryfibrosisandsystemicsclerosisassociatedinterstitiallungdisease
AT johnsembrat disparateinterferonsignalingandsharedaberrantbasaloidcellsinsinglecellprofilingofidiopathicpulmonaryfibrosisandsystemicsclerosisassociatedinterstitiallungdisease
AT humbertoetrejobittar disparateinterferonsignalingandsharedaberrantbasaloidcellsinsinglecellprofilingofidiopathicpulmonaryfibrosisandsystemicsclerosisassociatedinterstitiallungdisease
AT mauriciorojas disparateinterferonsignalingandsharedaberrantbasaloidcellsinsinglecellprofilingofidiopathicpulmonaryfibrosisandsystemicsclerosisassociatedinterstitiallungdisease
AT robertlafyatis disparateinterferonsignalingandsharedaberrantbasaloidcellsinsinglecellprofilingofidiopathicpulmonaryfibrosisandsystemicsclerosisassociatedinterstitiallungdisease